In this study, we conducted immunohistochemical (IHC) studies of CTLA-4, PD-1, PD-L1, and CD8 using 464 gastric cancer tissue microarrays and evaluated the expression of molecular markers related to immune checkpoint inhibition. This evidence concerns the gene CTLA4 and gastric cancer.